Michael Zinda - Jan 30, 2023 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, Chief Scientific Officer
Signature: /s/ Steve Forte, Attorney-in-Fact
Stock symbol: RPTX
Transactions as of: Jan 30, 2023
Transactions value $: $0
Form type: 4
Date filed: 2/1/2023, 08:46 PM
Previous filing: Mar 16, 2022
Next filing: Jun 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Award	$0	+24.6K	+53.32%	$0.00	70.6K	Jan 30, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Award	$0	+97.1K		$0.00	97.1K	Jan 30, 2023	Common Shares	97.1K	$12.42	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
F2	Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.